MOTS-c and Its Relatives: Humanin, Small Humanin-Like Peptides and the Mitochondrial-Derived Peptide Family

RESEARCH · MOTS-C · MDP FAMILY

MOTS-c and Its Relatives: Humanin, Small Humanin-Like Peptides and the Mitochondrial-Derived Peptide Family

PurixLab’s MOTS-C 10mg is a research vial of a 16-amino-acid peptide encoded in mitochondrial DNA. Our earlier articles cover a MOTS-c research overview and exercise, AMPK and nuclear signalling. This article steps back to look at MOTS-c as one member of a small family, the mitochondrial-derived peptides (MDPs), alongside humanin and the small humanin-like peptides (SHLPs). What do they share, where do they differ, and what is still unresolved? The material is supplied for laboratory research use only, and nothing here describes effects of any PurixLab product.

Humanin: the first mitochondrial-derived peptide

Humanin was found by functional expression screening: a cDNA from an Alzheimer’s disease brain library encoded a short polypeptide that abolished neuronal cell death caused by several familial Alzheimer’s disease genes and by Abeta, and the polypeptide was secreted into the culture medium [1]. Follow-up work identified essential roles for Cys8 and Ser14, and the S14G variant (HNG) was the only factor tested that abolished cytotoxicity from all of the Alzheimer’s-relevant insults in the comparison [2]. Its origin was puzzling from the start: the 1567-base cDNA was 99% identical to mitochondrial 16S ribosomal RNA, so antibody work was needed to show that a 3-kDa humanin-immunoreactive protein is actually produced in mouse tissues [3].

Guo and colleagues then showed that humanin, a 24-amino-acid peptide, binds Bax and prevents its translocation from the cytosol to mitochondria. They noted that the mitochondrial genome contains an identical open reading frame and speculated that humanin arose from mitochondria and transferred to the nuclear genome [4]. That dual-origin question has not gone away: in mice, the humanin-encoding Mtrnr2 is described as a mitochondrial pseudogene, and a humanin-like peptide is encoded by the nuclear gene Gm20594 [5].

Humanin signals largely from outside the cell

Much of humanin’s pharmacology involves partners at or beyond the cell surface. It binds insulin-like growth factor-binding protein 3 (IGFBP-3) with high affinity and specificity [6]; it acts on the G protein-coupled formylpeptide receptor-like-1 (FPRL1), a receptor also used by Abeta42 [7]; and its neuroprotection required gp130, with humanin inducing hetero-oligomerisation of CNTFR, WSX-1 and gp130 [8]. Downstream, humanin acted through the GP130/IL6ST receptor complex to activate AKT, ERK1/2 and STAT3 [9]. In rodents, humanin delivered into the brain ventricles improved overall insulin sensitivity through hypothalamic STAT-3 signalling, and circulating humanin decreased with age in humans and mice [10].

Small humanin-like peptides

An in silico search of the same 16S rRNA region of mtDNA revealed six additional peptides, named small humanin-like peptides [11]. They differed in their ability to regulate cell viability. SHLP2 and SHLP3 shared humanin-like protective effects, reducing apoptosis and reactive oxygen species and improving mitochondrial metabolism in vitro, and centrally delivered SHLP2 increased glucose uptake and suppressed hepatic glucose production in clamp studies; like humanin, circulating SHLP2 decreased with age [11]. A naturally occurring mtDNA variant, m.2158T>C, replaces lysine 4 of SHLP2 with arginine (K4R) and is associated with reduced Parkinson’s disease risk; the variant peptide was more stable, and targeted mass spectrometry detected SHLP2 tryptic fragments in neuronal cells and showed binding to mitochondrial complex 1 [12].

MOTS-c: a 12S rRNA peptide that reaches the nucleus

MOTS-c came out of the search for further short open reading frames after humanin. A sORF within the mitochondrial 12S rRNA encodes the 16-amino-acid peptide, whose cellular actions inhibit the folate cycle and its tethered de novo purine biosynthesis, leading to AMPK activation, with skeletal muscle as its apparent primary target organ [13]. Unlike humanin’s receptor-based signalling, MOTS-c translocates to the nucleus after metabolic stress in an AMPK-dependent manner and regulates a broad range of nuclear genes, including those with antioxidant response elements [14].

What the family shares and where it differs

By 2022, reviews counted eight published MDPs: humanin, MOTS-c and SHLPs 1–6 [15,16]. MOTS-c is encoded in the 12S rRNA gene (MT-RNR1), whereas humanin and SHLP1–6 are encoded in the 16S rRNA gene (MT-RNR2). Humanin, SHLP6 and MOTS-c are on the heavy strand, SHLP1–5 on the light strand, and mitochondrial translation uses its own genetic code, in which UGA codes for tryptophan [17].

  • Shared themes. Obesity, diabetes and aging are associated with lower circulating MDPs, and treating rodents with humanin, MOTS-c or SHLP2 can enhance insulin sensitivity [16].
  • Different routes. Humanin binds Bax and uses cell-surface receptor complexes [4,7,8]; MOTS-c works through the folate cycle, AMPK and nuclear translocation [13,14]; SHLP2 binds mitochondrial complex 1 [12].
  • Genetic variants. A humanin P3S variant enriched in centenarians carrying APOE4 attenuated brain amyloid-beta accumulation in an APOE4 mouse model compared with wild-type humanin [18], alongside the SHLP2 K4R variant above [12].
  • New members. An Alzheimer’s-associated mtDNA SNP mapped to another sORF, SHMOOSE, whose peptide fragments the authors describe as the first unique mass spectrometry-based detection of a mitochondrial-encoded microprotein [19].

Humanin also has the most extensive lifespan data in the family: overexpression extended lifespan in C. elegans in a daf-16/Foxo-dependent way, and children of centenarians had much higher circulating humanin than age-matched controls [20]. Human data that measure several family members together remain observational; in one study of 198 men undergoing prostate biopsy, plasma SHLP2, humanin and MOTS-c were each associated with lower prostate cancer risk in European American men but not in African American men [21].

What remains open

  • Which genome makes the peptide? Nuclear humanin-like sequences complicate attribution of a measured signal to mtDNA [4,5].
  • Detection. Unique mass-spectrometric evidence for mitochondrial-encoded microproteins is recent [19,12], so peptide-specific methods matter when interpreting circulating levels.
  • Cross-talk. We found no study testing whether humanin, SHLPs and MOTS-c interact or compensate for one another in the same model; most work studies one peptide at a time.
  • Translation to humans. Mechanistic findings come from cells and rodents, while human evidence is associative [16,21].

MOTS-C 10mg at PurixLab

MOTS-C 10mg: a labelled lyophilized research vial with 10mg per vial, C$54 per vial (CAD, before tax), supplied for laboratory research only. Batch documentation is available on request. Product page: purixlab.com/product/mots-c-10mg/.

PurixLab ships within Canada only, from stock held in Toronto. Standard shipping is C$15, and shipping is free when the product subtotal is C$200 or more after discounts. Orders outside the GTA ship by Canada Post Xpresspost. Prices are in CAD and taxes are calculated from your shipping address at checkout.

In Toronto and the GTA, our own team delivers orders the same day or the next day. There is no fixed GTA delivery fee: after you place your order, we email you to confirm the delivery time and any delivery charge, and then you pay. There is no storefront or local pickup.

Payment is by Interac e-Transfer (instructions are shown at checkout) or by cryptocurrency through Plisio (Bitcoin, Ethereum, USDT and more): choose Plisio at checkout and you are sent to a secure Plisio payment page after placing the order. Current offers and any pack pricing are shown on the product page and in your cart; offers do not stack.

For laboratory research use only. Not for human or veterinary use, not for consumption, injection or application to skin, and purchasers must be 18 or older. The studies summarised above describe specific materials in published research; they are not claims about any PurixLab product.

View MOTS-C 10mg

Questions or batch documentation requests: [email protected] · Shipping & Delivery · Toronto & GTA delivery · PurixLab FAQ

References

  1. Hashimoto Y, Niikura T, Tajima H, et al. A rescue factor abolishing neuronal cell death by a wide spectrum of familial Alzheimer's disease genes and Abeta. Proc Natl Acad Sci U S A. 2001;98(11):6336-41. PubMed 11371646 · PMC33469 · doi:10.1073/pnas.101133498
  2. Hashimoto Y, Niikura T, Ito Y, et al. Detailed characterization of neuroprotection by a rescue factor humanin against various Alzheimer's disease-relevant insults. J Neurosci. 2001;21(23):9235-45. PubMed 11717357 · PMC6763898 · doi:10.1523/JNEUROSCI.21-23-09235.2001
  3. Tajima H, Niikura T, Hashimoto Y, et al. Evidence for in vivo production of Humanin peptide, a neuroprotective factor against Alzheimer's disease-related insults. Neurosci Lett. 2002;324(3):227-31. PubMed 12009529 · doi:10.1016/s0304-3940(02)00199-4
  4. Guo B, Zhai D, Cabezas E, et al. Humanin peptide suppresses apoptosis by interfering with Bax activation. Nature. 2003;423(6938):456-61. PubMed 12732850 · doi:10.1038/nature01627
  5. Kim J, Choi JW, Namkung J. Expression Profile of Mouse Gm20594, Nuclear-Encoded Humanin-Like Gene. J Lifestyle Med. 2021;11(1):13-22. PubMed 33763338 · PMC7957044 · doi:10.15280/jlm.2021.11.1.13
  6. Ikonen M, Liu B, Hashimoto Y, et al. Interaction between the Alzheimer's survival peptide humanin and insulin-like growth factor-binding protein 3 regulates cell survival and apoptosis. Proc Natl Acad Sci U S A. 2003;100(22):13042-7. PubMed 14561895 · PMC240741 · doi:10.1073/pnas.2135111100
  7. Ying G, Iribarren P, Zhou Y, et al. Humanin, a newly identified neuroprotective factor, uses the G protein-coupled formylpeptide receptor-like-1 as a functional receptor. J Immunol. 2004;172(11):7078-85. PubMed 15153530 · doi:10.4049/jimmunol.172.11.7078
  8. Hashimoto Y, Kurita M, Aiso S, et al. Humanin inhibits neuronal cell death by interacting with a cytokine receptor complex or complexes involving CNTF receptor alpha/WSX-1/gp130. Mol Biol Cell. 2009;20(12):2864-73. PubMed 19386761 · PMC2695794 · doi:10.1091/mbc.e09-02-0168
  9. Kim SJ, Guerrero N, Wassef G, et al. The mitochondrial-derived peptide humanin activates the ERK1/2, AKT, and STAT3 signaling pathways and has age-dependent signaling differences in the hippocampus. Oncotarget. 2016;7(30):46899-46912. PubMed 27384491 · PMC5216912 · doi:10.18632/oncotarget.10380
  10. Muzumdar RH, Huffman DM, Atzmon G, et al. Humanin: a novel central regulator of peripheral insulin action. PLoS One. 2009;4(7):e6334. PubMed 19623253 · PMC2709436 · doi:10.1371/journal.pone.0006334
  11. Cobb LJ, Lee C, Xiao J, et al. Naturally occurring mitochondrial-derived peptides are age-dependent regulators of apoptosis, insulin sensitivity, and inflammatory markers. Aging (Albany NY). 2016;8(4):796-809. PubMed 27070352 · PMC4925829 · doi:10.18632/aging.100943
  12. Kim SJ, Miller B, Hartel NG, et al. A naturally occurring variant of SHLP2 is a protective factor in Parkinson's disease. Mol Psychiatry. 2024;29(2):505-517. PubMed 38167865 · PMC11116102 · doi:10.1038/s41380-023-02344-0
  13. Lee C, Zeng J, Drew BG, et al. The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance. Cell Metab. 2015;21(3):443-54. PubMed 25738459 · PMC4350682 · doi:10.1016/j.cmet.2015.02.009
  14. Kim KH, Son JM, Benayoun BA, et al. The Mitochondrial-Encoded Peptide MOTS-c Translocates to the Nucleus to Regulate Nuclear Gene Expression in Response to Metabolic Stress. Cell Metab. 2018;28(3):516-524.e7. PubMed 29983246 · PMC6185997 · doi:10.1016/j.cmet.2018.06.008
  15. Miller B, Kim SJ, Kumagai H, et al. Mitochondria-derived peptides in aging and healthspan. J Clin Invest. 2022;132(9):e158449. PubMed 35499074 · PMC9057581 · doi:10.1172/JCI158449
  16. Merry TL, Chan A, Woodhead JST, et al. Mitochondrial-derived peptides in energy metabolism. Am J Physiol Endocrinol Metab. 2020;319(4):E659-E666. PubMed 32776825 · PMC7750512 · doi:10.1152/ajpendo.00249.2020
  17. Kal S, Mahata S, Jati S, et al. Mitochondrial-derived peptides: Antidiabetic functions and evolutionary perspectives. Peptides. 2024;172:171147. PubMed 38160808 · PMC10838678 · doi:10.1016/j.peptides.2023.171147
  18. Miller B, Kim SJ, Cao K, et al. Humanin variant P3S is associated with longevity in APOE4 carriers and resists APOE4-induced brain pathology. Aging Cell. 2024;23(7):e14153. PubMed 38520065 · PMC11258485 · doi:10.1111/acel.14153
  19. Miller B, Kim SJ, Mehta HH, et al. Mitochondrial DNA variation in Alzheimer's disease reveals a unique microprotein called SHMOOSE. Mol Psychiatry. 2023;28(4):1813-1826. PubMed 36127429 · PMC10027624 · doi:10.1038/s41380-022-01769-3
  20. Yen K, Mehta HH, Kim SJ, et al. The mitochondrial derived peptide humanin is a regulator of lifespan and healthspan. Aging (Albany NY). 2020;12(12):11185-11199. PubMed 32575074 · PMC7343442 · doi:10.18632/aging.103534
  21. Ramirez-Torres A, Reagan AL, Howard LE, et al. Racial differences in circulating mitochondria-derived peptides may contribute to prostate cancer health disparities. Prostate. 2022;82(13):1248-1257. PubMed 35789022 · PMC9388542 · doi:10.1002/pros.24398

Leave a Comment

Your email address will not be published. Required fields are marked *